studi
multicent
evalu
life
technolog
taqman
array
card
tac
custom
viral
bacteri
respiratori
assay
perform
appli
biosystem
viia
tm
realtim
pcr
system
goal
studi
demonstr
analyt
perform
platform
compar
ident
individu
pathogen
specif
laboratori
develop
test
ldt
design
center
diseas
control
prevent
cdc
equival
ldt
provid
state
public
health
laboratori
three
differ
commerci
multirespiratori
panel
cdc
associ
public
health
laboratori
aphl
ldt
similar
analyt
sensit
viral
pathogen
sever
bacteri
pathogen
aphl
ldt
demonstr
sensit
one
log
higher
correspond
cdc
ldt
compar
cdc
ldt
tac
assay
gener
one
two
log
less
sensit
depend
site
perform
analysi
final
tac
assay
gener
sensit
counterpart
three
differ
commerci
multirespiratori
panel
tac
technolog
allow
user
spot
custom
assay
design
tac
layout
simplifi
assay
setup
conserv
specimen
dramat
reduc
contamin
potenti
demonstr
studi
analyz
multipl
sampl
parallel
good
reproduc
instrument
oper
molecular
method
includ
realtim
pcr
becom
prefer
approach
prompt
test
respiratori
tract
specimen
presenc
viral
bacteri
pathogen
convent
techniqu
frequent
labor
intens
time
consum
less
sensit
often
requir
special
expertis
andor
facil
remain
valuabl
case
cultureindepend
test
reduc
sensit
exampl
includ
http
elsevi
bv
right
reserv
emerg
new
type
subtyp
evad
molecular
detect
cumul
effect
genet
drift
reduc
detect
sensit
cultur
method
also
use
clinic
microbiolog
antimicrobi
suscept
test
rapid
report
realtim
test
result
give
health
profession
greater
flexibl
patient
manag
provid
epidemiologist
time
recogn
respond
outbreak
addit
test
result
may
allow
appropri
antimicrobi
treatment
help
prevent
spread
secondari
infect
develop
multipl
drug
resist
speci
realtim
pcr
demonstr
enhanc
sensit
specif
util
compar
tradit
method
culturedfa
mahoni
includ
abil
simultan
detect
multipl
pathogen
mengel
et
al
babadi
pillet
et
al
choudhari
et
al
weinberg
et
al
kodani
et
al
quantifi
pathogen
load
potenti
identifi
new
pathogen
multiplex
pcr
attract
term
throughput
conserv
reagent
specimen
requir
extens
optim
easili
amen
chang
compon
without
entir
revalid
perform
assay
henegariu
et
al
markoulato
et
al
sever
commerci
platform
assay
exist
simultan
detect
multipl
respiratori
pathogen
specimen
includ
luminex
xtag
respiratori
viral
panel
luminex
corpor
austin
texa
qiagen
resplex
qiagen
hilden
germani
tessara
rpm
flu
tessara
llc
potomac
fall
virginia
along
system
biofir
diagnost
holog
genmark
diagnost
pathofind
fasttrack
diagnost
nanospher
platform
differ
varieti
featur
includ
type
number
analys
perform
viral
bacteri
mix
influenza
specif
detect
technolog
need
dedic
instrument
complex
sensit
throughput
cost
per
specimen
compar
evalu
sever
panel
show
good
specif
vari
level
sensit
across
pathogen
sakthivel
et
al
renaud
et
al
popowitch
et
al
babadi
et
al
gadsbi
et
al
rand
et
al
driscol
et
al
one
common
theme
among
commerci
platform
end
user
control
menu
assay
includ
panel
abil
custom
individu
assay
without
incur
signific
development
cost
time
prepar
manuscript
qiagen
resplex
panel
tessara
longer
avail
altern
taqman
array
card
tac
life
technolog
carlsbad
california
low
densiti
microfluid
card
arrang
specimen
assay
array
total
individu
realtim
pcr
reaction
studi
present
manuscript
carri
use
tac
partit
array
sampl
uniqu
assay
perform
duplic
shown
fig
tac
associ
posit
control
materi
kodani
winchel
design
detect
respiratori
pathogen
kodani
et
al
waller
et
al
steensel
et
al
hepat
genom
enteropathogen
liu
et
al
plattsmil
et
al
bioterror
agent
rachwal
et
al
assay
independ
modif
one
primerprob
set
requir
revalid
entir
tac
thu
event
assay
updat
new
tac
would
manufactur
incorpor
design
chang
design
tac
also
help
minim
specimen
handl
requir
less
input
templat
nucleic
acid
equival
number
individu
pcr
reaction
studi
compar
analyt
sensit
reproduc
tac
spot
oligonucleotid
detect
individu
respiratori
pathogen
individu
laboratori
develop
test
ldt
three
differ
multipathogen
viral
bacteri
refer
standard
use
studi
except
influenza
influenza
b
streptococcu
pneumonia
streptococcu
pyogen
obtain
qualiti
control
molecular
diagnost
qcmd
glasgow
scotland
influenza
b
obtain
influenza
reagent
resourc
irr
manassa
va
pneumonia
pyogen
obtain
bacteriolog
laboratori
wadsworth
center
assay
name
abbrevi
refer
standard
shown
tabl
laboratori
develop
test
ldt
detect
viral
bacteri
respiratori
pathogen
design
clinic
laboratori
improv
amend
certifi
laboratori
center
diseas
control
prevent
cdc
atlanta
georgia
two
differ
state
public
health
laboratori
phl
individu
realtim
pcr
assay
serv
refer
standard
tac
perform
could
compar
pathogen
specif
assay
tac
cdc
phl
ldt
adapt
use
tac
commerci
assay
includ
xtag
respiratori
viral
panel
fast
resplex
tessarray
rpm
extract
protocol
use
studi
valid
multipl
phl
determin
compar
extract
effici
differ
pathogen
variou
matric
sensit
assess
use
quantifi
refer
viral
bacteri
standard
determin
tac
layout
cdc
respiratori
assay
includ
viral
bacteri
target
maximum
densiti
card
arrang
specimen
assay
array
maximum
total
individu
realtim
pcr
reaction
tac
also
manufactur
format
studi
card
partit
specimen
assay
subarray
assay
perform
duplic
adjac
well
squar
b
column
repres
singl
assay
abbrevi
shown
parenthesi
except
intern
posit
control
ipco
manufactur
control
gapdh
human
coronaviru
assay
spot
singl
well
within
column
column
card
also
includ
rna
control
sampl
port
one
reserv
use
neg
control
permit
seven
sampl
analyz
tac
limit
detect
lod
assay
accord
publish
user
instruct
packag
insert
quantit
perform
individu
assay
part
qiagen
resplex
ii
panel
luminex
xtag
respiratori
viral
panel
fast
tessarray
rpm
flu
panel
establish
two
step
first
rang
find
experi
perform
identifi
endpoint
detect
evid
next
lod
determin
test
replic
sampl
sever
differ
dilut
refer
standard
serial
dilut
viral
transport
media
store
c
prior
extract
instrument
reaction
condit
summar
tabl
duplic
sampl
extract
purifi
nucleic
acid
pool
store
c
analysi
qiagen
resplex
luminex
xtag
data
perform
use
mean
fluoresc
intens
unit
mfi
cutoff
valu
list
tabl
lod
determin
analysi
replic
sampl
three
differ
dilut
one
log
endpoint
endpoint
one
log
endpoint
wherebi
replic
test
posit
detect
analysi
tessarray
data
perform
use
score
andor
evalu
list
tabl
dilut
refer
standard
initi
test
five
individu
array
lod
subsequ
determin
analysi
replic
sampl
array
two
differ
dilut
endpoint
one
log
endpoint
wherebi
replic
test
posit
detect
quantit
perform
cdc
ldt
establish
manner
similar
commerci
panel
describ
rang
find
experi
first
perform
bracket
detect
endpoint
lod
subsequ
determin
analysi
replic
sampl
three
differ
dilut
lod
calcul
indic
dilut
wherebi
replic
test
posit
detect
instrument
reaction
condit
summar
tabl
primer
probe
sequenc
along
final
oligonucleotid
concentr
given
tabl
assay
perform
use
l
dilut
extract
nucleic
acid
l
reaction
laboratori
develop
test
detect
individu
respiratori
pathogen
independ
design
ny
ia
quantit
perform
assay
establish
manner
cdc
ldt
instrument
reaction
condit
summar
tabl
primer
probe
sequenc
along
final
oligonucleotid
concentr
given
tabl
assay
perform
use
l
dilut
extract
nucleic
acid
custom
configur
tac
kodani
et
al
diaz
et
al
design
detect
viral
bacteri
target
two
adjac
well
sampl
squar
b
fig
tac
manufactur
target
specif
primer
probe
solut
lyophil
well
extract
nucleic
acid
l
combin
agpathid
onestep
rtpcr
reagent
thermofish
scientif
waltham
l
reaction
mixtur
load
one
sampl
port
port
load
reaction
mixtur
distribut
throughout
tac
low
speed
centrifug
also
rehydr
lyophil
oligonucleotid
assay
parainfluenza
viru
tac
updat
better
perform
c
annealingextens
temperatur
use
studi
see
tabl
therefor
perform
data
present
assay
tac
also
includ
assay
human
coronaviru
howev
assay
character
due
lack
appropri
refer
standard
case
column
repres
singl
assay
spot
duplic
well
shown
fig
howev
ipco
gapdh
human
coronaviru
assay
spot
singl
well
within
column
column
duplic
test
reduc
probabl
fals
neg
due
sampl
variat
near
lod
compens
singl
defect
microfluid
channel
tac
sampl
port
one
reserv
use
neg
control
permit
seven
sampl
analyz
tac
sinc
ident
refer
standard
use
studi
known
combin
posit
control
includ
verifi
individu
assay
perform
quantit
perform
individu
pathogen
specif
viral
bacteri
assay
tac
establish
manner
cdc
ldt
except
lod
calcul
indic
dilut
wherebi
replic
test
posit
detect
sampl
prepar
serial
dilut
univers
transport
media
copan
diagnost
murrieta
ca
store
c
prior
extract
particip
state
phl
use
prefer
extract
method
either
roch
magna
pure
lc
system
total
nucleic
acid
isol
kit
hi
wa
wi
biomerieux
nuclisen
easymag
ia
ny
iowa
use
inputelut
volum
l
site
use
l
primer
probe
sequenc
along
final
oligonucleotid
concentr
given
tabl
tac
run
abi
viia
realtim
pcr
instrument
configur
tac
heat
block
use
follow
cycl
paramet
c
min
c
min
follow
cycl
c
c
min
realtim
fluoresc
intens
data
examin
manual
tac
confirm
posit
amplif
intern
posit
control
neg
amplif
templat
control
ntc
proven
refer
viral
bacteri
standard
suppli
manufactur
therefor
absenc
presenc
amplif
rnase
p
examin
result
use
qualifi
analysi
assay
integr
confirm
examin
tac
crossamplif
tac
also
monitor
presenc
anomal
baselin
fluoresc
note
reproduc
amplif
adjac
well
fig
squar
b
atyp
result
may
caus
defect
spot
oligonucleotid
differ
assay
microfluid
channel
distribut
specimen
throughout
tac
centrifug
lod
cdc
ldt
evalu
two
differ
state
laboratori
two
differ
realtim
pcr
instrument
abi
fast
dx
well
heat
block
result
present
tabl
highest
dilut
lowest
concentr
extract
refer
standard
met
accept
criteria
experi
calcul
lod
two
instrument
ident
column
ad
site
except
rhinoviru
adenoviru
ldt
column
b
meet
accept
criteria
cdc
ldt
also
demonstr
good
reproduc
log
across
six
state
phl
shown
column
b
e
f
g
h
apart
human
parainfluenza
viru
assay
also
meet
necessari
criteria
wi
site
compar
ldt
develop
new
york
state
depart
health
column
cdc
ldt
demonstr
similar
sensit
except
cdc
human
parainfluenza
viru
ldt
whose
lod
log
higher
sensit
tessarray
qiagen
luminex
panel
gener
log
lower
cdc
phl
ldt
except
qiagen
respiratori
enteroviru
assay
one
log
sensit
lod
reproduc
also
evalu
seven
differ
cdc
phl
ldt
design
detect
bacteri
pathogen
associ
common
respiratori
infect
select
assay
perform
six
state
phl
result
present
tabl
sensit
similar
cdc
ia
ldt
column
b
except
cdc
legionella
spp
ldt
meet
statist
threshold
inclus
posit
detect
sever
ny
ldt
demonstr
better
sensit
includ
haemophilu
influenza
legionella
pneumophila
mycoplasma
pneumonia
pneumonia
precis
across
six
state
phl
within
log
column
e
f
perform
differ
cdc
design
ldt
tac
format
evalu
six
particip
state
phl
lod
determin
assay
three
differ
laboratori
site
tabl
limit
detect
cdc
phl
viral
respiratori
ldt
well
format
commerci
multirespiratori
panel
result
meet
accept
criteria
least
replic
test
posit
detect
consid
indetermin
lod
express
highest
dilut
lowest
concentr
extract
refer
standard
met
accept
criteria
experi
posit
detect
b
posit
detect
c
posit
detect
posit
detect
na
assay
assign
site
nd
panel
design
detect
rhinoviru
test
combin
viral
bacteri
assay
shown
tabl
compar
lod
data
ldt
well
format
tabl
sensit
tac
format
gener
one
two
log
lower
depend
assay
test
site
precis
also
vari
depend
assay
human
coronaviru
human
coronaviru
human
metapneumoviru
influenza
influenza
b
human
parainfluenza
viru
human
parainfluenza
viru
rhinoviru
h
influenza
assay
best
reproduc
adenoviru
bordetella
pertussi
assay
standard
deviat
log
studi
associ
public
health
laboratori
aphl
cdc
cooper
six
phl
conduct
multicent
evalu
tac
technolog
viral
bacteri
respiratori
assay
overal
goal
evalu
analyt
perform
cdc
develop
refer
assay
tac
comparison
individu
cdc
laboratori
develop
test
ldt
ldt
two
differ
state
phl
three
commerci
multitarget
respiratori
panel
sensit
gener
one
log
lower
tac
tabl
limit
detect
cdc
viral
bacteri
respiratori
assay
tac
format
lod
express
highest
dilut
lowest
concentr
extract
refer
standard
met
accept
criteria
experi
format
individu
ldt
consist
previou
studi
kodani
et
al
may
due
oligonucleotid
concentr
fulli
optim
tac
addit
smaller
reaction
volum
l
per
assay
compar
typic
realtim
assay
l
smaller
reaction
volum
conserv
specimen
comparison
individu
multiplex
realtim
pcr
assay
leav
greater
residu
specimen
volum
use
molecular
microbi
character
addit
cdc
viral
ldt
optim
anneal
temperatur
c
bacteri
ldt
design
use
c
bacteri
ldt
perform
well
c
data
shown
viral
ldt
accept
higher
anneal
temperatur
sinc
type
assay
includ
tac
compromis
made
run
assay
anneal
temperatur
c
previou
studi
compar
sensit
specif
reproduc
tac
detect
viral
bacteri
pathogen
capabl
caus
respiratori
infect
individu
realtim
pcr
assay
well
format
wet
assay
use
clinic
specimen
one
studi
examin
viru
posit
specimen
sensit
specif
tac
respect
kodani
et
al
wherea
differ
studi
test
specimen
valu
weinberg
et
al
detect
sensit
describ
previou
studi
vari
depend
target
adenoviru
human
parainfluenza
viru
pneumonia
chlamydophila
pneumonia
assay
demonstr
lower
perform
reproduc
cycl
threshold
ct
valu
within
across
tac
two
studi
also
good
averag
coeffici
variat
final
posit
neg
predict
perform
studi
also
similar
tac
tradit
individu
wet
assay
separ
follow
tac
studi
found
sensit
near
lod
could
improv
optim
entir
test
procedur
includ
evalu
differ
enzym
system
adjust
oligonucleotid
concentr
increas
number
replic
two
four
diaz
et
al
comparison
two
studi
cite
purpos
current
studi
evalu
analyt
sensit
tac
assay
individu
ldt
use
refer
standard
measur
reproduc
multipl
site
regardless
specimen
type
assay
tac
demonstr
sensit
specif
reproduc
equival
multipathogen
detect
platform
one
limit
current
studi
lod
calcul
term
infecti
dose
id
copiesml
futur
studi
evalu
tac
perform
valid
laboratori
develop
test
use
clinic
specimen
known
titer
sever
differ
extract
instrument
combin
oligonucleotid
primer
probe
pcr
enzym
master
mix
realtim
instrument
use
multipl
laboratori
studi
consist
result
demonstr
robust
techniqu
assay
care
design
thoroughli
valid
taken
collect
data
underscor
util
tac
multipathogen
test
perform
varieti
specimen
type
use
variou
extract
amplif
chemistri
although
inher
logist
limit
exist
attempt
compar
technolog
result
current
studi
demonstr
tac
ideal
platform
test
specimen
use
custom
panel
target
support
suitabl
tac
futur
studi
varieti
format
set
